DK1838318T3 - Anvendelse af oxycodon til behandling af visceral smerte - Google Patents

Anvendelse af oxycodon til behandling af visceral smerte

Info

Publication number
DK1838318T3
DK1838318T3 DK06700652T DK06700652T DK1838318T3 DK 1838318 T3 DK1838318 T3 DK 1838318T3 DK 06700652 T DK06700652 T DK 06700652T DK 06700652 T DK06700652 T DK 06700652T DK 1838318 T3 DK1838318 T3 DK 1838318T3
Authority
DK
Denmark
Prior art keywords
oxycodone
treatment
visceral pain
visceral
pain
Prior art date
Application number
DK06700652T
Other languages
English (en)
Inventor
Asbjorn Mohr Drewes
Lars Arendt Nielsen
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35871217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1838318(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1838318T3 publication Critical patent/DK1838318T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
DK06700652T 2005-01-18 2006-01-17 Anvendelse af oxycodon til behandling af visceral smerte DK1838318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64549005P 2005-01-18 2005-01-18
PCT/EP2006/050252 WO2006077212A1 (en) 2005-01-18 2006-01-17 Use of oxycodone for treating visceral pain

Publications (1)

Publication Number Publication Date
DK1838318T3 true DK1838318T3 (da) 2010-01-04

Family

ID=35871217

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06700652T DK1838318T3 (da) 2005-01-18 2006-01-17 Anvendelse af oxycodon til behandling af visceral smerte
DK200700207U DK200700207U3 (da) 2005-01-18 2007-07-24 Anvendelse af oxycodon til behandling af visceral smerte

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200700207U DK200700207U3 (da) 2005-01-18 2007-07-24 Anvendelse af oxycodon til behandling af visceral smerte

Country Status (32)

Country Link
US (2) US20080200493A1 (da)
EP (1) EP1838318B1 (da)
JP (1) JP5049139B2 (da)
KR (10) KR20200128451A (da)
CN (1) CN101106996B (da)
AP (1) AP2249A (da)
AR (1) AR052880A1 (da)
AT (2) ATE446092T1 (da)
AU (1) AU2006207498B2 (da)
BR (1) BRPI0606247A2 (da)
CA (1) CA2595043C (da)
CY (1) CY1109660T1 (da)
DE (2) DE602006009899D1 (da)
DK (2) DK1838318T3 (da)
EA (1) EA013544B1 (da)
ES (1) ES2333901T3 (da)
HK (1) HK1107933A1 (da)
HR (1) HRP20090679T1 (da)
IL (1) IL184530A (da)
ME (1) ME01066B (da)
MX (1) MX2007007207A (da)
MY (1) MY144471A (da)
NO (1) NO338968B1 (da)
NZ (1) NZ555852A (da)
PL (1) PL1838318T3 (da)
PT (1) PT1838318E (da)
RS (1) RS51069B (da)
SI (1) SI1838318T1 (da)
TW (1) TWI432196B (da)
UA (1) UA85471C2 (da)
WO (1) WO2006077212A1 (da)
ZA (1) ZA200705231B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2008004467A0 (en) 2005-11-14 2008-06-30 Rinat Neurosciene Corp Antagonist antibodies directed against calcitonin generelated peptide anf methods using same
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
BRPI0907135B8 (pt) 2008-03-04 2021-05-25 Labrys Biologics Inc uso de um anticorpo antagonista anti-cgrp para a prevenção e/ou tratamento de dor de câncer crônica
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
AU2010288194B2 (en) 2009-08-28 2013-08-29 Teva Pharmaceuticals International Gmbh Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
DK2710039T3 (da) 2011-05-20 2019-04-01 Alderbio Holdings Llc Anti-cgrp-sammensætninger og anvendelse deraf
SG194973A1 (en) 2011-05-20 2013-12-30 Alderbio Holdings Llc Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
EP2709662B1 (en) 2011-05-20 2019-07-31 AlderBio Holdings LLC Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
MX2016012188A (es) 2014-03-21 2017-04-27 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos.
JP6937368B2 (ja) 2016-09-23 2021-09-22 テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー 難治性片頭痛の治療方法
KR20210094513A (ko) 2018-11-19 2021-07-29 재즈 파마슈티칼즈 아일랜드 리미티드 알코올-내성 약물 제형
CR20210373A (es) 2019-01-08 2021-08-19 H Lundbeck As Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656295A (en) * 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
NZ332039A (en) * 1996-03-25 2000-06-23 Lilly Co Eli Method for treating pain using olanzapine and NSAIDs
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US6992193B2 (en) * 2003-06-10 2006-01-31 Adolor Corporation Sulfonylamino phenylacetamide derivatives and methods of their use

Also Published As

Publication number Publication date
CY1109660T1 (el) 2014-08-13
BRPI0606247A2 (pt) 2009-06-09
JP5049139B2 (ja) 2012-10-17
KR20120089710A (ko) 2012-08-13
JP2008526927A (ja) 2008-07-24
WO2006077212A1 (en) 2006-07-27
EP1838318A1 (en) 2007-10-03
KR20190135557A (ko) 2019-12-06
KR20210131450A (ko) 2021-11-02
TWI432196B (zh) 2014-04-01
KR20200128451A (ko) 2020-11-12
EA200701541A1 (ru) 2008-02-28
CN101106996A (zh) 2008-01-16
CA2595043C (en) 2013-11-19
CN101106996B (zh) 2013-10-23
NO20074174L (no) 2007-10-17
NZ555852A (en) 2010-01-29
KR20230170811A (ko) 2023-12-19
AU2006207498A1 (en) 2006-07-27
KR20220165797A (ko) 2022-12-15
ZA200705231B (en) 2008-06-25
AP2249A (en) 2011-07-18
AT9895U1 (de) 2008-05-15
ES2333901T3 (es) 2010-03-02
RS51069B (sr) 2010-10-31
KR20080106991A (ko) 2008-12-09
AP2007004057A0 (en) 2007-08-31
HK1107933A1 (en) 2008-04-25
UA85471C2 (ru) 2009-01-26
PT1838318E (pt) 2009-12-15
ATE446092T1 (de) 2009-11-15
US9271974B2 (en) 2016-03-01
EP1838318B1 (en) 2009-10-21
US20150190393A1 (en) 2015-07-09
DK200700207U1 (da) 2007-08-24
ME01066B (me) 2012-10-20
AU2006207498B2 (en) 2009-11-19
EA013544B1 (ru) 2010-06-30
MY144471A (en) 2011-09-30
IL184530A (en) 2015-01-29
KR20170021905A (ko) 2017-02-28
NO338968B1 (no) 2016-11-07
MX2007007207A (es) 2007-08-15
DE602006009899D1 (de) 2009-12-03
KR20070100368A (ko) 2007-10-10
DK200700207U3 (da) 2007-09-28
AR052880A1 (es) 2007-04-11
DE202006019887U1 (de) 2007-07-26
CA2595043A1 (en) 2006-07-27
SI1838318T1 (sl) 2010-02-26
IL184530A0 (en) 2007-10-31
TW200637554A (en) 2006-11-01
HRP20090679T1 (hr) 2010-01-31
PL1838318T3 (pl) 2010-03-31
KR20140091782A (ko) 2014-07-22
US20080200493A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
DK1838318T3 (da) Anvendelse af oxycodon til behandling af visceral smerte
DE602005027052D1 (de) Endoskopbehandlungssystem
DK2409728T3 (da) System til ultralydsbehandling af væv
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK1863899T3 (da) Hudbehandlingspræparater
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
CY2200156T2 (el) Επεξεργασια λυματων
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
EP1968591A4 (en) TREATMENT OF SYNUCLEINOPATHIES
DE602005021084D1 (de) ENDOSKOPisches BEHANDLUNGSSYSTEM
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
SI1890705T1 (sl) Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP2007790A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN
DK2001499T3 (da) Anvendelse af TGS-6 til behandling af osteoporose
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0602857D0 (en) The treatment of sialorrhoea
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0500024D0 (en) The treatment of pre-term labour
GB0518003D0 (en) Treatment of hepatatis c